A carregar...
Infliximab Treatment of Refractory Cardiac Sarcoidosis
Treatment of cardiac sarcoidosis is challenging, as the disease can be refractory to traditional treatment with steroids. Infliximab, a tumor necrosis factor-α inhibitor, has been reportedly used in cardiac sarcoidosis, but published evidence is limited. The potential cardiotoxicity of infliximab an...
Na minha lista:
| Publicado no: | JACC Case Rep |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8302154/ https://ncbi.nlm.nih.gov/pubmed/34317016 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaccas.2020.06.041 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|